|
000
| 01479cam 22002778a 4500 |
|---|
| 001 | 9.844013 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107152642 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 170919s2017 onca o f000 0 eng d |
|---|
| 020 | |a978-0-660-09799-2 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-29/1-2017E-PDF |
|---|
| 245 | 00|aAlignment among public formularies in Canada, part 1. |h[electronic resource] |pGeneral overview. |
|---|
| 260 | |aOttawa : |bPatented Medicine Prices Review Board, |c2017. |
|---|
| 300 | |aiii, 31 p. : |bfigs. |
|---|
| 500 | |aIssued also in French under title: Concordance des listes de médicaments des régimes publics au Canada, partie 1 : Aperçu général. |
|---|
| 500 | |aCover title. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"This first report in the series provides insight into the degree of alignment among the formularies. Based on 2015 data, this analysis compares the overall drug listings and unpacks specific market segments including single- and multi-source drugs, high-cost drugs, and a specified list of essential medicines."--Executive summary, p. ii. |
|---|
| 692 | 07|2gccst|aDrugs |
|---|
| 692 | 07|2gccst|aDrug insurance |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 775 | 08|tConcordance des listes de médicaments des régimes publics au Canada, partie 1. |w(CaOODSP)9.844019 |
|---|
| 856 | 40|qPDF|s1.83 MB|uhttps://publications.gc.ca/collections/collection_2017/cepmb-pmprb/H82-29-1-2017-eng.pdf |
|---|